(firstQuint)Expanded Treatment Protocol in Acute Lymphoblastic Leukemia.

 This is a single arm, open-label, multi-center, phase II study to determine the safety and efficacy of CTL019 in pediatric/young adult patients with r/r B-cell ALL.

 The study will have the following sequential phases: Screening, Pre-Treatment (Cell Product Preparation &amp; Lymphodepleting Chemotherapy), Treatment and Follow-up.

 The total duration of the study is 1 year from CTL019 cell infusion.

.

 Expanded Treatment Protocol in Acute Lymphoblastic Leukemia@highlight

This is a single arm, open-label, multi-center, phase II study to determine the safety and efficacy of CTL019 in pediatric/young adult patients with r/r B-cell ALL.

